IPP Bureau
Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification
By IPP Bureau - November 21, 2025
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Innovent Biologics’ experimental weight-loss drug achieves breakthrough in Phase 3 trial
By IPP Bureau - November 21, 2025
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
EMA launches streamlined process to fast-track critical medicines, vaccines
By IPP Bureau - November 21, 2025
The move is expected to be crucial during health crises
.png "in-cosmetics Asia 2025 smashes records, draws global beauty elite")
in-cosmetics Asia 2025 smashes records, draws global beauty elite
By IPP Bureau - November 21, 2025
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Thyrocare launches comprehensive GLP-1 health check across India
By IPP Bureau - November 21, 2025
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
FDA nod to Koselugo for adults with Rare NF1 tumors, expanding life-changing treatment
By IPP Bureau - November 21, 2025
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
By IPP Bureau - November 21, 2025
The initiative aims to connect startups and tech companies with its business units,
Lilly expands biotech footprint with new Gateway Labs in Philadelphia
By IPP Bureau - November 21, 2025
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
By IPP Bureau - November 19, 2025
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Cardiol Therapeutics wins US patent protection for heart-disease drug platform
By IPP Bureau - November 19, 2025
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Meduloc wins FDA green light for new class of bone-fracture fixation system
By IPP Bureau - November 19, 2025
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
Roche’s Giredestrant sets new benchmark in early breast cancer treatment
By IPP Bureau - November 19, 2025
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
.png "Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening")
Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
By IPP Bureau - November 19, 2025
India presents one of the world’s largest untapped opportunities for neurovascular screening
